Cargando…

Unmet Needs in Pharmacological Treatment of Apathy in Alzheimer’s Disease: A Systematic Review

Background: Apathy is one of the most prevalent neuropsychiatric symptoms encountered in Alzheimer’s disease (AD) and may be an early sign in the development of dementia persisting over the disease course. It has been associated with poor disease outcome, impaired daily functioning, and significant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Theleritis, Christos G., Siarkos, Kostas T., Politis, Antonios M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797825/ https://www.ncbi.nlm.nih.gov/pubmed/31680942 http://dx.doi.org/10.3389/fphar.2019.01108

Ejemplares similares

A Systematic Review of Pharmacological Interventions for Apathy in Aging Neurocognitive Disorders
por: Theleritis, Christos, et al.
Publicado: (2023)

Editorial: Ocular Pharmacology: Recent Breakthroughs and Unmet Needs
por: Bucolo, Claudio, et al.
Publicado: (2022)

Pharmacologic Approaches for the Management of Apathy in Neurodegenerative Disorders
por: Bogdan, Anamaria, et al.
Publicado: (2020)

A Review of Treatment of Coronavirus Disease 2019 (COVID-19): Therapeutic Repurposing and Unmet Clinical Needs
por: Chen, Po-Lin, et al.
Publicado: (2020)

Apathy in Alzheimer's disease
por: Nobis, Lisa, et al.
Publicado: (2018)

Treating Rare Diseases in Africa: The Drugs Exist but the Need Is Unmet
por: Luzzatto, Lucio, et al.
Publicado: (2022)

Advances in Alzheimer’s disease’s pharmacological treatment
por: Conti Filho, Carlos Elias, et al.
Publicado: (2023)

Apathy in Alzheimer's Disease: Any Effective Treatment?
por: Rea, Raffaele, et al.
Publicado: (2014)

An Update on Apathy in Alzheimer’s Disease
por: Dolphin, Helena, et al.
Publicado: (2023)

Advances in Multi-Functional Ligands and the Need for Metal-Related Pharmacology for the Management of Alzheimer Disease
por: Sharma, Abha, et al.
Publicado: (2018)

Editorial: The Challenge of New Therapeutic Approaches for Unmet Therapeutic Needs
por: Rosa, Arianna Carolina, et al.
Publicado: (2020)

Pharmacological Treatment of Depression in Alzheimer’s Disease: A Challenging Task
por: Cassano, Tommaso, et al.
Publicado: (2019)

Neurobiologic Rationale for Treatment of Apathy in Alzheimer’s Disease With Methylphenidate
por: van Dyck, Christopher H., et al.
Publicado: (2020)

Noradrenergic therapies for apathy in Alzheimer’s disease?
por: Husain, Masud
Publicado: (2023)

Pharmacological Potential of Cilostazol for Alzheimer’s Disease
por: Ono, Kenjiro, et al.
Publicado: (2019)

Mapping new pharmacological interventions for cognitive function in Alzheimer’s disease: a systematic review of randomized clinical trials
por: Xu Lou, Inmaculada, et al.
Publicado: (2023)

Brain Perfusion Correlates of Apathy in Alzheimer's Disease
por: Jeong, Hyeonseok, et al.
Publicado: (2018)

Experimental Pharmacology in Transgenic Rodent Models of Alzheimer’s Disease
por: Cuello, A. Claudio, et al.
Publicado: (2019)

Network Pharmacology-Based Analysis of Xiao-Xu-Ming Decoction on the Treatment of Alzheimer’s Disease
por: Shen, Yanjia, et al.
Publicado: (2020)

Microglia: A pharmacological target for the treatment of age-related cognitive decline and Alzheimer’s disease
por: McKee, Chloe G., et al.
Publicado: (2023)

Bupropion for the Treatment of Apathy in Alzheimer Disease: A Randomized Clinical Trial
por: Maier, Franziska, et al.
Publicado: (2020)

Pharmacodynamics, Network Pharmacology, and Pharmacokinetics of Chinese Medicine Formula 9002A in the Treatment of Alzheimer’s Disease
por: Tang, Chunlan, et al.
Publicado: (2022)

Pharmacological effects of natural medicine ginsenosides against Alzheimer’s disease
por: Shi, Zhikun, et al.
Publicado: (2022)

Non-pharmacologic interventions to treat apathy in Parkinson’s disease: A realist review
por: Mele, Bria, et al.
Publicado: (2021)

Pimavanserin: A Novel Antipsychotic With Potentials to Address an Unmet Need of Older Adults With Dementia-Related Psychosis
por: Yunusa, Ismaeel, et al.
Publicado: (2020)

Apathy, cognitive function and motor function in Alzheimer's disease
por: Hernandez, Salma S. Soleman, et al.
Publicado: (2012)

Pharmacological models in Alzheimer's disease research
por: Gilles, Christian, et al.
Publicado: (2000)

Different Doses of Pharmacological Treatments for Mild to Moderate Alzheimer’s Disease: A Bayesian Network Meta-Analysis
por: Zhang, Tingting, et al.
Publicado: (2020)

The New Paradigms in Clinical Research: From Early Access Programs to the Novel Therapeutic Approaches for Unmet Medical Needs
por: Scavone, Cristina, et al.
Publicado: (2019)

Pharmacological Targeting of the Hepcidin/Ferroportin Axis
por: Sebastiani, Giada, et al.
Publicado: (2016)

Apathy in Parkinson’s Disease: Defining the Park Apathy Subtype
por: De Waele, Ségolène, et al.
Publicado: (2022)

Systematic Review and Pharmacological Considerations for Chloroquine and Its Analogs in the Treatment for COVID-19
por: Peng, Hongwei, et al.
Publicado: (2020)

Systems Pharmacology Approach to Investigate the Mechanism of Kai-Xin-San in Alzheimer’s Disease
por: Luo, Yunxia, et al.
Publicado: (2020)

Awareness, apathy, and depression in Alzheimer's disease and mild cognitive impairment
por: Jacus, Jean‐Pierre
Publicado: (2017)

Revisiting Apathy in Alzheimer's Disease: From Conceptualization to Therapeutic Approaches
por: Teixeira, Antonio L., et al.
Publicado: (2021)

Use of methylphenidate in alzheimer’s dementia: Effect on apathy
por: Borralho, R., et al.
Publicado: (2021)

An Overview of Systematic Reviews of Chinese Herbal Medicine for Alzheimer’s Disease
por: Liu, Nanyang, et al.
Publicado: (2021)

Unmet Needs in the Treatment of Gastroesophageal Reflux Disease
por: Dickman, Ram, et al.
Publicado: (2015)

The Association Between Impaired Awareness and Depression, Anxiety, and Apathy in Mild to Moderate Alzheimer's Disease: A Systematic Review
por: Azocar, Ignacia, et al.
Publicado: (2021)

Corrigendum: Systems pharmacology approach to investigate the mechanism of Kai-Xin-San in Alzheimer’s disease
por: Luo, Yunxia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3i7noalil5l6ko69rtls0suvni